DOI: 10.1148/radiol.2343031976
Breast Cancer Yield for Screening Mammographic Examinations with Recommendation for Short-Interval Follow-up1
Karla Kerlikowske, MD,
Rebecca Smith-Bindman, MD,
Linn A. Abraham, MS,
Constance D. Lehman, MD, PhD,
Bonnie C. Yankaskas, PhD,
Rachel Ballard-Barbash, MD, MPH,
William E. Barlow, PhD,
Jennifer H. Voeks, PhD,
Berta M. Geller, EdD,
Patricia A. Carney, PhD and
Edward A. Sickles, MD
1 From the Depts of Medicine and Epidemiology and Biostatistics (K.K.) and Radiology (R.S.B., E.A.S.), Univ of California, San Francisco; General Internal Medicine Section, San Francisco Veterans Affairs Medical Ctr, 111A1, 4150 Clement St, San Francisco, CA 94121 (K.K.); Ctr for Health Studies, Group Health Cooperative, Seattle, Wash (L.A., C.L., W.E.B.); Dept of Radiology, Univ of Washington Medical Ctr, Seattle Cancer Care Alliance, Seattle, Wash (C.L.); Dept of Radiology, Univ of North Carolina, Chapel Hill (B.C.Y.); Applied Research Program, DCCPS, National Cancer Institute, Bethesda, Md (R.B.B.); Dept of Biostatistics, Univ of Washington, Seattle (W.E.B.); Cancer Research and Biostatistics, Seattle, Wash (W.E.B.); Ctr for Research Methods and Biometry, The Cooper Institute, Denver, Colo (J.H.V.); Health Promotion Research, Univ of Vermont, College of Medicine, Burlington (B.M.G.); and Norris Cotton Cancer Ctr/Dartmouth-Hitchcock Medical Ctr/Dept of Community and Family Medicine, Dartmouth Medical School, Lebanon, NH (P.A.C.). Received Dec 17, 2003; revision requested Feb 23, 2004; final revision received May 11; accepted Jun 18. Supported by a NCI-funded Breast Cancer Surveillance Consortium cooperative agreement (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA63731, U01CA70040). Address correspondence to K.K. (e-mail: kerliko@itsa.ucsf.edu).

View larger version (22K):
[in a new window]
|
Figure 1. Graph shows time to detection and proportion of cancers in first screening examinations with a PBF assessment. Most cancers associated with a recommendation for short-interval follow-up are detected within 12 months of a screening examination. After 12 months, the detection of cancer is constant over time. NA = not applicable.
|
|

View larger version (23K):
[in a new window]
|
Figure 2. Graph shows time to detection and proportion of cancers in subsequent screening examinations with a PBF assessment. Most cancers associated with a recommendation for short-interval follow-up are detected within 12 months of a screening examination. After 12 months, the detection of cancer is constant over time. NA = not applicable.
|
|
Copyright © 2005 by the Radiological Society of North America.